Oxford Prostate Research Centre (OPRC)
Oxford has a critical mass of prostate cancer research groups with our activity ranging from basic biology to clinical trials research.
Our interests and expertise are broad, including metabolic biology (Mills, Macaulay, Edwards), tumour/bone microenvironment (Edwards, Parkes), tumour evolution (Woodcock, Lamb), pathology AI (Verrill, Colling, Browning), multimodal experimental therapies (Bryant, Macaulay, Hamdy), spatial genomics (Lamb, Mills, Woodcock, Verrill), AI-powered data analytics (Woodcock), clinical trials (Bryant, Lamb, Hamdy, Macaulay, Parkes, Protheroe), metastatic biology (Edwards, Macaulay), immunology (Parkes), quality tissue collections & biobanking (Verrill, Browning, Colling, Lamb, Bryant, Hamdy, Protheroe). These research areas benefit from synergy between different groups, exemplified by our several jointly supervised DPhil students, and co-supervised postdoctoral positions. Our work is complemented by competitively funded centres in Oxford such as the CRUK Oxford Centre and NIHR Oxford BRC, as well as by several important national and international collaborations (see group pages).
The Oxford Prostate Research Centre (OPRC) brings together local expertise in prostate research – all with a focus on better understanding mechanisms of development and progression of prostate cancer, with a view to improving diagnosis and treatment for patients and their families.